Ruixia Ma
- Molecular Biology
- Nephrology top 2%
- Cancer Research top 10%
- Surgery
- Immunology
- Topics
- Renal Diseases and Glomerulopathies (14 papers)Chronic Kidney Disease and Diabetes (6 papers)Autophagy in Disease and Therapy (6 papers)
- Partner nations
- ChinaUnited StatesBulgaria
In The Last Decade
Ruixia Ma
48 papers receiving 807 citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 379
- Nephrology 232
- Cancer Research 209
- Surgery 102
- Immunology 80
Countries citing papers authored by Ruixia Ma
This map shows the geographic impact of Ruixia Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruixia Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruixia Ma more than expected).
Fields of papers citing papers by Ruixia Ma
This network shows the impact of papers produced by Ruixia Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruixia Ma. The network helps show where Ruixia Ma may publish in the future.
Co-authorship network of co-authors of Ruixia Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Ruixia Ma. A scholar is included among the top collaborators of Ruixia Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruixia Ma. Ruixia Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 12 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 6 | |
| 8 | 9 | |
| 9 | 1 | |
| 10 | 11 | |
| 11 | 3 | |
| 12 | 49 | |
| 13 | 1 | |
| 14 | 25 | |
| 15 | 41 | |
| 16 | 26 | |
| 17 | 1 | |
| 18 | [Triptolide combined with irbesartan synergistically blocks podocyte injury in a type 2 diabetes rat model]. | 3 |
| 19 | 2 | |
| 20 | Effect of Triptolide on podocyte injury and its mechanism in the kidney of 2 type diabetic rats | 1 |
About Ruixia Ma
Ruixia Ma is a scholar working on Nephrology, Obstetrics and Gynecology and Oral Surgery, having authored 51 papers that have together received 819 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (14 papers), Chronic Kidney Disease and Diabetes (6 papers) and Autophagy in Disease and Therapy (6 papers). The work is most often cited by research in Nephrology (232 citations), Cancer Research (209 citations) and Complementary and alternative medicine (59 citations). Ruixia Ma has collaborated with scholars based in China, United States and Bulgaria. Frequent co-authors include Yaguang Xi, Hong Chang, Hongyou Zhao, Bin Yi, Xiaoguo Zhang, Liqiu Liu, Xuemei Liu, Congjuan Luo, Wei Jiang and Huifang Wang. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.